Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01892462 · ClinicalTrials.gov registry record
Circulating Biomarkers and Ventricular Tachyarrhythmia
A clinical trial, sponsored by Ochsner Health System.
- Completed
- Registry status
- 220
- Enrollment target
NCT01892462 is a clinical trial that has completed, run by Ochsner Health System. The registered enrollment target is 220 participants.
The verdict
NCT01892462 has completed, sponsored by Ochsner Health System.
- COMPLETED
- Registry status
- 220 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether levels of inflammatory markers in circulating blood can correlate with risk for dangerous heart rhythms. Patients with systolic heart failure, which has been shown to increase risk for dangerous heart rhythms, will be enrolled. All subjects will have an implantable cardioverter-defibrillator (ICD) in place, which allows regular evaluation of heart rhythm.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2012-06 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01892462
The ClinicalTrials.gov registry entry for NCT01892462 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ochsner Health System, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01892462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01892462 about?
NCT01892462 is a clinical study titled "Circulating Biomarkers and Ventricular Tachyarrhythmia". The purpose of this study is to determine whether levels of inflammatory markers in circulating blood can correlate with risk for dangerous heart rhythms. Patients with systolic heart failure, which has been shown to increase risk for dangerous heart rhythms, will be enrolled. All subjects will have...
What is the current status of trial NCT01892462?
This trial is currently completed. The enrollment target is 220 participants. The study started on 2012-06. Estimated completion is 2016-10.
Who is sponsoring clinical trial NCT01892462?
This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.